- Home
- ARCC vs COO Comparison
ARCC vs COO Comparison
Compare ARCC & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCC
- COO
- Stock Information
- Founded
- ARCC 2004
- COO 1980
- Country
- ARCC United States
- COO United States
- Employees
- ARCC N/A
- COO N/A
- Industry
- ARCC Finance/Investors Services
- COO Ophthalmic Goods
- Sector
- ARCC Finance
- COO Health Care
- Exchange
- ARCC Nasdaq
- COO Nasdaq
- Market Cap
- ARCC 15.8B
- COO 13.4B
- IPO Year
- ARCC 2004
- COO N/A
- Fundamental
- Price
- ARCC $19.09
- COO $69.76
- Analyst Decision
- ARCC Buy
- COO Buy
- Analyst Count
- ARCC 9
- COO 10
- Target Price
- ARCC $23.00
- COO $78.70
- AVG Volume (30 Days)
- ARCC 6.6M
- COO 2.6M
- Earning Date
- ARCC 10-28-2025
- COO 08-27-2025
- Dividend Yield
- ARCC 10.05%
- COO N/A
- EPS Growth
- ARCC N/A
- COO 13.33
- EPS
- ARCC 2.03
- COO 2.04
- Revenue
- ARCC $3,011,000,000.00
- COO $4,045,700,000.00
- Revenue This Year
- ARCC $3.21
- COO $6.02
- Revenue Next Year
- ARCC $5.02
- COO $5.71
- P/E Ratio
- ARCC $9.39
- COO $34.14
- Revenue Growth
- ARCC 6.85
- COO 6.35
- 52 Week Low
- ARCC $18.26
- COO $61.78
- 52 Week High
- ARCC $23.84
- COO $109.37
- Technical
- Relative Strength Index (RSI)
- ARCC 19.56
- COO 53.32
- Support Level
- ARCC $20.03
- COO $68.55
- Resistance Level
- ARCC $20.43
- COO $71.02
- Average True Range (ATR)
- ARCC 0.40
- COO 1.53
- MACD
- ARCC -0.10
- COO 0.41
- Stochastic Oscillator
- ARCC 3.67
- COO 70.40
About ARCC Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.